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Quick guidesWhy did you move back to China? First of all, I feel extremely privileged 
to be educated and trained at the 
University of Minnesota. There are 
many superb scientists studying 
vision and brain imaging there. 
My collaboration with them led 
to some intriguing findings on 
visual adaptation, unconscious 
visual processing, and contextual 
modulation in early visual cortical 
areas. From them I learned not just 
experimental skills, but also various 
distinct perspectives on these same 
scientific questions. 
Career-wise, working in China is 
very attractive to me. Government 
research funds in China have been 
growing at an annual rate of more 
than 20%. Ample funding allows me 
to explore and carry out much larger 
and more risky projects. At Peking 
University, I have been enjoying 
working with the country’s most 
intelligent and hardworking students. 
In addition, I am a big ping-pong and 
soccer fan, and living in China gives 
me a lot more opportunity to enjoy 
these sports.
Tell us something about 
neuroscience in China? 
Neuroscience in China has a tradition 
of excellence. I would like to mention 
the founders of modern Chinese 
neuroscience — Robert Kho-Seng 
Lim, Te-Pei Feng and Hsiang-Tung 
Chang. Lim and Feng were members 
of the US National Academy 
of Sciences. Lim carried out 
pioneering work on the physiology of 
neuromuscular junction and synaptic 
plasticity. Interested readers might 
want to read a chapter published in 
the Annual Review of Neuroscience 
in 1988 (11, 1–12) about Lim’s career 
development and the early history 
of neuroscience in China. Chang 
was one of the pioneers of studying 
dendritic potentials and among 
the first to recognize the functional 
significance of dendrites in the 
central nervous system.
Neuroscience in China has grown 
steadily since the 1920s, and 
started to flourish in the 1990s. In 
1995, the Chinese Neuroscience 
Society was founded and it now has 
more than 2500 members. Major 
neuroscience research programs 
are located in the Chinese Academy 
of Sciences, Peking University, 
Fudan University, Beijing Normal 
University, University of Science and Technology of China, many 
medical universities and institutes, 
and many more places. Research 
areas include molecular, cellular 
and developmental neurobiology, 
systems and computational 
neuroscience, as well as cognitive 
and behavioral neuroscience. 
Chinese neuroscientists are making 
their contribution to the development 
of this field on a par with their 
peers in the international arena, 
as demonstrated by their frequent 
publications in almost all prestigious 
journals (including Current Biology).
And what about psychology in 
China? Psychology, on the other 
hand, took a slightly different turn.  
In 1917, the first psychology 
laboratory in China was set 
up at Peking University, under 
the guidance of the university 
president Yuen-Pei Tsai. Tsai 
studied psychology with Wilhelm 
Wundt when he was in Germany. 
Unfortunately, the development of 
psychology was suppressed for a 
long time, even halted during the 
Cultural Revolution from 1966 to 
1976. This is because psychology 
was criticized as a pseudo-science. 
In 1981, only four universities 
had a psychology department. 
Interestingly, the turning point for 
the development of psychology was 
also in the 1990s, almost in parallel 
with the time when neuroscience 
started to thrive. Up to now, 
there are more than two hundred 
psychology departments/institutes in 
China. Founded in 1921, the Chinese 
Psychological Society now has 
about 8000 members. Psychological 
research in China covers almost all 
basic and applied fields. Brain and 
cognitive science has been identified 
as one of the eight research frontiers 
by the central government in 2006 
and two national key laboratories 
have been set up targeting 
fundamental issues in this area. The 
rapid development of psychology 
(and neuroscience) in China is partly 
due to the nation’s economic boom 
and thus a rapid growth in research 
funds. I feel honored to live in this 
era and to experience the dramatic 
(positive) changes of science and 
research in China. 
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What are Argonaute proteins? 
Argonaute proteins form an 
evolutionarily conserved family  
whose members silence gene 
expression in pathways such as RNA 
interference (RNAi). Argonaute family 
proteins can be divided into AGO and 
PIWI proteins (Figure 1). Both types of 
Argonaute proteins bind 21–35 nt long 
small RNA guides whose sequence 
identifies the genes to be silenced. 
Argonaute–small-RNA complexes can 
repress the transcription of genes, 
target mRNAs for site-specific cleavage 
or general degradation, or block mRNA 
translation into protein. AGO proteins 
bind ~21 nt small interfering RNAs 
(siRNAs) and 21–23 nt microRNAs 
(miRNAs). Both siRNAs and miRNAs 
are cut from double-stranded RNA 
precursors by RNase III enzymes such 
as Dicer. AGO proteins are essential for 
development and differentiation, and in 
most plants and animals, defend cells 
against viral infection. In contrast, PIWI 
proteins bind 23–30 nt PIWI-interacting 
RNAs (piRNAs), whose production does 
not appear to involve double-stranded 
RNA or Dicer. piRNAs are unique to 
animals, where they repress transposon 
expression and ensure the successful 
production of sperm and eggs.
How do Argonautes function? An 
Argonaute protein plus its small RNA 
guide compose the RNA-induced 
silencing complex (RISC). RISC 
complexes can also contain additional 
proteins thought to extend the 
functions of Argonautes or to direct 
RISC to specific sub-cellular locations. 
The simplest, and likely ancestral, 
Argonaute function is endonucleolytic 
cleavage of its RNA target at a single 
phosphodiester bond. The structure 
of Argonaute ensures that the bond 
cleaved always lies between the 
target nucleotides paired to the tenth 
and eleventh nucleotides of the 
guide RNA. Increasingly, Argonaute 
aficionados refer to these nucleotides 
as g10 and g11 for the small RNA and 
t10 and t11 for the target, viewing both 
the guide (g) and the target (t) from  
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Figure 1. Sequence relationships among AGO and PIWI sub-families of Argonaute proteins.
Protein sequences from the thermophilic bacterium Aquifex aeolicus (Aa), the sulfur-reduc-
ing archaea Archaeoglobus fulgidus (Af), the eubacteria Thermus thermophilus (Tt), the 
yeast Schizosaccharomyces pombe (Sp), the plant Arabidopsis thaliana (At), and the animals 
Drosophila melanogaster (Dm), Homo sapiens (Hs), and Nematostella vectensis (Nv; sea 
anemone) were aligned using MUSCLE (http://www.ebi.ac.uk/Tools/msa/muscle/) and 
displayed using Archaeopteryx 0.957beta (http://www.phylosoft.org/archaeopteryx/).the 5´-to-3´ perspective of the small 
silencing RNA.
What does Argonaute look like? 
No three-dimensional structure is 
available for an entire eukaryotic 
Argonaute protein, but a series of 
structures of eubacterial and archaeal 
Argonautes, as well as structures 
of individual domains of eukaryotic 
Argonaute proteins, together reveal 
broad principles that hold true in fungi, 
plants, and animals. All Argonaute/Piwi  
proteins comprise three key domains: 
PIWI, MID, and PAZ (Figure 2). The 
Argonaute endonuclease, which 
requires Mg2+ to slice a target RNA 
into products bearing 3´ hydroxyl and 
5´ phosphate groups, resides in the 
carboxy-terminal PIWI domain (Figure 
2A). The PIWI domain resembles 
another nuclease, RNase H, a  
DNA-guided ribonuclease. Like  
RNase H, the PIWI domain contains 
three negatively charged, evolutionarily 
conserved amino acids — typically 
aspartate-aspartate-glutamate  
(DDE) — that form a Mg2+-binding 
catalytic triad. Unlike RNase H, the 
small RNA guide remains stably bound 
to the Argonaute protein through many 
rounds of target cleavage.
The amino-terminal PAZ domain uses 
its oligonucleotide-binding (OB) fold  
to secure the 3´ end of the small  
RNA guide strand to Argonaute   
(Figure 2B). A conserved hydrophobic 
cavity within the PAZ domain 
recognizes the characteristic  
two-nucleotide, 3´ overhanging end 
of the guide-passenger siRNA or 
miRNA/miRNA* duplex generated by 
Dicer. The PAZ domain can also detect 
chemical modification of the 3´ end of 
the small RNA. In plants, all small RNAs 
bear a 2´-O-methyl modification at their 
final ribose sugar. In animals, piRNAs, 
but not typically miRNAs or siRNAs, 
are 2´-O-methyl modified, although in 
insects siRNAs bound to Argonaute2 
are also 2´-O-methyl modified. The 
PAZ domains of human PIWI proteins 
(Hiwi1, Hiwi2, Hili) bind more tightly to 
the two-nucleotide, 3´ overhanging end 
of a dsRNA when it bears a 2´-O-methyl 
than when the end is 2´ hydroxyl. 
Conversely, the PAZ domain of the 
human AGO protein Ago1 prefers a 2´ 
hydroxyl. Comparison of the structures 
of single-stranded RNA bound to the 
PAZ domain from mouse Miwi with that 
of the PAZ domain from human Ago1 
suggests that the wider RNA-binding 
cleft of the Miwi PAZ domain better accommodates a terminal 2´-O-methyl 
group than does that of Ago1. However, 
Drosophila Ago1 — whose guide RNAs 
in vivo are thought always to end with 
a 2´ OH — can accept 2´-O-methyl 
guides, at least in vitro.
Finally, the MID domain anchors the 
5´ monophosphate of a small silencing 
RNA to the Argonaute protein, securing 
the guide through multiple cycles of 
target cleavage (Figure 2A). In vitro 
studies suggest that 5´ phosphate 
binding helps align the small RNA on 
the surface of Argonaute, ensuring 
that the correct bond of the target is 
positioned in the endonuclease active 
site. The MID domain also participates 
in sorting small RNAs among various 
Argonaute paralogs according to the 
identity of the first nucleotide of the 
RNA guide. For example, in Arabidopsis 
Ago1 prefers small RNAs that begin with uridine, Ago2 and Ago4 prefer 
an initial adenosine, and Ago5 prefers 
cytosine. Swapping the MID domain of 
one Arabidopsis Argonaute for that of 
another exchanges the initial nucleotide 
that is favored. Such nucleotide 
preferences likely arise from subtle 
differences in the amino acid side 
chains near the 5´ phosphate-binding 
pocket: structures of the human Ago2 
MID domain bound to nucleoside 
monophosphates suggest that Ago2 
favors small RNAs that begin with 
uridine or adenosine because a rigid 
loop in the domain inhibits binding to 
cytidine or guanosine. 
How do Argonautes obtain their 
small RNA guides? On their own, AGO 
proteins do not accept an siRNA or 
miRNA/miRNA* duplex, yet all available 
evidence suggests that AGO proteins 
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Figure 2. The domains of Argonaute proteins.
(A) The structure of Thermus thermophilus Argonaute (PDB ID 3HM9) shows the three key 
functional domains common to all Argonaute proteins: the single-stranded RNA-binding PAZ 
domain (purple), the PIWI endonuclease domain (green) with its characteristic catalytic triad 
(D478, D546 and D660 in T. thermophilus) that cleaves the target RNA (dark blue), and the MID 
domain, which binds the 5´ phosphate and first nucleotide of the nucleic acid guide (red; here, 
a DNA guide, but typically an RNA in eukaryotes). Adapted from Wang et al. (2009). (B) The 
structure of the Drosophila melanogaster Ago2 PAZ domain (PDB ID 1T2R) reveals how this 
domain binds the 3´ single-stranded tail of the guide RNA. Amino acids are colored according 
to their chemical properties: hydrophobic, yellow; acidic, pink; and basic, blue. Adapted from 
Lingel et al. (2004).are initially loaded with double-stranded 
small RNAs, which then mature to  
single-stranded RNA-containing, 
functional RISC. Loading of a small 
RNA duplex into an AGO protein 
requires both ATP and the chaperones 
Hsc70 and Hsp90. Hsc70 and Hsp90 
are thought to use ATP energy to open 
AGO proteins to permit them to bind 
double-stranded small RNAs, but the 
details of this process remain unknown.
In Drosophila, mammals, and likely 
other higher plants and animals, 
RISC complexes load a small RNA 
duplex in a defined orientation: the 
thermodynamically less stable 5´ end of 
the double-stranded small RNA ends 
up in the phosphate-binding pocket 
of the MID domain, establishing that 
strand as the future small RNA guide. 
The other RNA strand becomes the 
passenger. Such thermodynamic asymmetry, together with first 
nucleotide identity, determines which 
strand of a small RNA duplex becomes 
the guide for an AGO protein. Most 
small RNA duplexes preferentially 
produce a readily predictable siRNA 
guide or miRNA strand, although some 
are bi-functional, with both strands 
loaded into AGO proteins. Even for 
these ‘symmetric’ small RNAs, a single 
molecule of duplex can only load one 
of its two strands; the other strand is 
ultimately destroyed.
An AGO protein bound to an siRNA 
or miRNA/miRNA* duplex is called  
pre-RISC. Once the siRNA passenger or 
miRNA* strand of the duplex small RNA 
is evicted from pre-RISC, the complex 
becomes mature RISC. For catalytically 
active AGO proteins, the siRNA 
passenger strand is thought to be 
cleaved as if it were a target mRNA. The heterodimeric protein C3PO has 
been proposed to facilitate release 
of the cleaved passenger strand. For 
catalytically inactive AGO proteins, 
mismatches within the duplex — in the 
seed or between guide positions g12 
to g15 — promote maturation of  
pre-RISC to RISC.
Many eukaryotes produce multiple 
Argonaute proteins, which are often 
functionally distinct. Flies and plants, 
for example, devote different AGO 
proteins to the RNAi and miRNA 
pathways. Caenorhabditis elegans 
produces 27 Argonautes (including two 
PIWI proteins). Mice and humans make 
four AGO proteins, only one of which, 
Ago2, retains the ability to cleave its 
RNA targets. Whether the functions 
of Ago1, Ago3, and Ago4 differ is not 
known.
How does Argonaute recognize  
and repress its mRNA targets? The 
‘seed sequence’ of a small silencing 
RNA guide — nucleotides 2 to 7 or 2 to 
8 — provides nearly all of the specificity 
for target binding. Argonaute proteins 
pre-organize the seed sequence 
into a one-stranded helix whose 
conformation makes it ready to pair 
with a target without loss of entropy. 
Argonaute proteins accomplish this 
by binding the negatively charged 
phosphodiester backbone of seed 
sequence nucleotides, displaying the 
edges of bases g2 to g8 so that they 
are ready to base-pair with t2 to t8 of a 
target mRNA.
Why the rest of the nucleotides of 
the small RNA guide contribute so little 
to target binding remains unexplained. 
The two-state model envisions that 
guide strand nucleotides 3´ to the 
seed sequence alternate between two 
isoenergetic conformations: bound 
to Argonaute, with the 3´ terminus 
anchored in the PAZ domain, and 
paired to the target mRNA, with the 
3´ end free in solution. The fixed-end 
model proposes that the 3´ end of the 
guide strand remains anchored in the 
PAZ domain at all times, irrespective 
of the presence of a target RNA. Both 
models assume that the 5´ end of the 
small RNA guide always resides in the 
MID domain phosphate-binding pocket.
The structures of T. thermophilus 
Argonaute bound to a DNA guide and 
to a DNA guide together with an RNA 
target support the two-state model: 
the 3´ end of the guide strand binds the 
PAZ domain when only the DNA guide 
is present, but not when a target RNA 
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of the catalytic amino acid triad move 
closer to the phosphodiester bond to 
be cut when the target RNA pairs with 
the guide. Much additional work will be 
needed to determine which, if either, 
of the two models best explains how 
Argonautes bind their targets.
Many Argonaute proteins lack a 
functional DDE catalytic triad and, 
thus, repress their targets through 
mechanisms other than endonucleolytic 
cleavage. For example, miRNA-guided 
Argonaute proteins such as fly or 
human Ago1 reduce the stability of 
their mRNA targets and can also block 
mRNA translation. The miRNA-binding 
Argonaute proteins, miRNAs, and 
their mRNA targets all localize to P 
bodies, cytoplasmic loci where general 
mRNA decay has been proposed to 
occur. In Drosophila and mammals, 
the Argonaute-binding protein GW182 
is required for miRNA-directed mRNA 
repression and the recruitment of 
Argonaute proteins to P bodies, but is 
dispensable for RNAi.
What do we know about how piRNAs 
are made and how they function? 
piRNAs guide PIWI proteins to silence 
transposons in the germ line of animals. 
We know little about the early steps in 
the biogenesis of piRNAs except that 
unlike siRNAs and miRNAs, piRNA 
production does not require Dicer and 
likely involves only single-stranded 
precursor RNAs.
Hints about the biogenesis of piRNAs 
and their role in transposon silencing 
come mainly from studies of Drosophila 
ovaries and testes. Drosophila gonads 
express three PIWI proteins: Piwi, 
Aubergine, and Ago3. Piwi localizes to 
the nucleus in both the germline and the 
surrounding somatic follicle cells, which 
help regulate the differentiation and 
patterning of the germline nurse cells 
and oocytes. Transposon-derived  
piRNAs bound to Piwi silence 
transposon expression in the nucleus 
by poorly understood mechanisms. In 
contrast, Ago3 and Aub reside in the 
germ cell cytoplasm.
What is the ‘Ping-Pong’ mechanism 
of amplification of piRNAs? High 
throughput sequencing of piRNAs 
bound to Piwi, Aubergine, and Ago3 
suggest a model, the ‘Ping-Pong’ 
mechanism, for how this class of 
small silencing RNAs is produced and 
subsequently amplified in response to 
transcription of the transposons they target. The Ping-Pong model proposes 
that Aubergine and Ago3 collaborate 
both to increase the abundance of 
piRNAs and to bias piRNAs toward 
the antisense strand. The detailed 
mechanism by which Aubergine 
and Piwi acquire primary piRNAs 
is unknown, but current evidence 
suggests they derive from long RNAs 
transcribed from ‘piRNA clusters’: 
transposon-rich, gene-poor regions 
of the genome which are specifically 
transcribed in the gonads. The  
Ping-Pong model postulates that 
Aubergine, bound to an anti-sense 
primary piRNA, pairs with the mRNA 
transcript of an active transposon, 
cleaving it in two and generating 
a 3´ cleavage product bearing a 5´ 
monophosphate. The 5´ end of the 3´ 
cleavage fragment then becomes the 5´ 
end of a sense piRNA bound to Ago3. 
This ‘secondary piRNA’ can then  
direct cleavage of a primary piRNA 
transcript derived from a piRNA cluster. 
The next step reverses the process: the 
Ago3–sense-piRNA complex cleaves 
the long transcript of a piRNA cluster, 
generating antisense RNA fragments 
that bind to Aub and are envisioned 
to be trimmed to piRNA length by an 
unidentified 3´-to-5´ exonuclease. 
In addition to the transposon-targeting 
piRNAs produced by the Ping-Pong 
cycle early in spermatogenesis 
(‘pre-pachytene piRNAs’), mammals 
generate piRNAs from non-repetitive 
but gene-poor loci as the developing 
spermatocytes enter the pachytene 
stage of meiosis. Mutations that 
block production of these pachytene 
piRNAs arrest spermatogenesis at 
the round spermatid stage. We do 
not know why pachytene piRNAs 
are required for mammalian sperm 
maturation or what genes or DNA 
structures pachytene piRNAs regulate. 
What is on the horizon? piRNAs 
protect the germline from invading 
transposons, but do they actually 
silence expression? We know that 
Piwi proteins cleave transposons 
to generate more piRNAs, which 
then cleave more transposons, but 
it remains to be established that this 
amplification cycle is the primary 
mechanism for transposon silencing 
by piRNAs. In many animals, piRNAs 
repress transcription, but we do not 
know how. Do Piwi proteins bind DNA 
or nascent transcripts? Do they recruit 
factors that alter chromatin structure or 
histone modifications?Moreover, piRNA biogenesis, 
especially primary piRNA production, 
remains obscure. Are the piRNA 
precursors transcribed from large 
clusters initially fragmented to generate 
the 5´ monophosphorylated ends of 
piRNAs, then trimmed by exonucleases 
to generate discrete 3´ ends? What 
is the function of piRNAs derived 
from non-repetitive sequences? In 
Drosophila embryos, piRNAs have 
recently been proposed to bind the 
3´ untranslated region (UTR) and 
promote deadenylation of the mRNA 
encoding Nanos, a protein required 
for anterior–posterior patterning of the 
developing embryo. Are piRNAs that 
map to 3´ UTRs generally involved in 
the temporal or spatial control of gene 
expression?
The sorting of small RNAs among 
different Argonaute proteins according 
to the structure and sequence of an 
siRNA or miRNA duplex suggests that 
each Argonaute protein might have a 
unique or specific regulatory function 
or that individual Argonautes might be 
specifically retained or degraded during 
cell differentiation. Yet no functional 
difference has been discovered 
distinguishing human Ago1, Ago3, 
and Ago4. Perhaps these three human 
AGOs bind different regulatory proteins. 
Defining the repertoire of proteins 
bound by each human Argonaute 
protein may help reveal their specific 
functions.
Where can I learn more?
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